SCHEMBL5705353

SCHEMBL5705353

CCCC(C)(CCCCCC(=O)CCCCCC(C)(CCC(O)O)c1ccccc1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.39
HIF1A Q16665 1/20 0.39
ASAH1 Q13510 2/20 0.35
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35
HDAC8 Q9BY41 5/20 0.34
HDAC3 O15379 3/20 0.34
HDAC6 Q9UBN7 3/20 0.34
HDAC1 Q13547 2/20 0.34
HDAC2 Q92769 2/20 0.34
ALDH1A1 P00352 1/20 0.34
ACER2 Q5QJU3 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34
HDAC10 Q969S8 1/20 0.34
HDAC11 Q96DB2 1/20 0.34
HDAC9 Q9UKV0 1/20 0.34
HDAC5 Q9UQL6 1/20 0.34
MAPT P10636 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5705246 0.99 CYP2C19 (0.40) CYP2C19HIF1AASAH1CES2CES1
SCHEMBL5705432 0.95 CYP2C19 (0.41) CYP2C19HIF1AKMT2ARIPK1CYP1A2
SCHEMBL3278666 0.81 CYP2C19 (0.51) CYP2C19HIF1AHDAC8HDAC3HDAC6
SCHEMBL7027001 0.81 CYP2C19 (0.40) CYP2C19HIF1AASAH1CES2CES1
SCHEMBL3286528 0.79 CYP2C19 (0.46) CYP2C19HIF1ACES2CES1HDAC8
SCHEMBL3279434 0.79 CYP2C19 (0.46) CYP2C19HIF1ACES2CES1HDAC8
SCHEMBL7021868 0.79 CYP2C19 (0.41) CYP2C19HIF1AASAH1ALDH1A1MAPT
SCHEMBL3280257 0.79 CYP2C19 (0.53) CYP2C19HIF1AHDAC8HDAC3HDAC6
SCHEMBL5705434 0.79 CYP2C19 (0.39) CYP2C19HIF1AALDH1A1MAPTKMT2A
SCHEMBL5705247 0.79 CYP2C19 (0.39) CYP2C19HIF1AALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1326822-A2 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES Esperion Therapeutics Inc. (US) 2003-07-16 EP claimed
WO-2002030860-A9 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS INC (US) 2003-02-20 WO claimed
WO-2002030860-A2 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2002-04-18 WO claimed
EP-1701931-A1 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES Esperion Therapeutics, Inc. (US) 2006-09-20 EP disclosed
WO-2005068412-A1 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2005-07-28 WO disclosed
EP-1326822-A2 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES Esperion Therapeutics Inc. (US) 2003-07-16 EP disclosed
WO-2002030860-A9 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS INC (US) 2003-02-20 WO disclosed
WO-2002030860-A2 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2002-04-18 WO disclosed